12:00 AM
 | 
Mar 19, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Firazyr icatibant regulatory update

The Scottish Medicines Consortium recommended the use of Firazyr icatibant from Sanofi on the National Health Service (NHS) in Scotland to treat acute attacks of...

Read the full 105 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >